143 related articles for article (PubMed ID: 18340112)
1. A chemotherapy-associated senescence bystander effect in breast cancer cells.
Di X; Bright AT; Bellott R; Gaskins E; Robert J; Holt S; Gewirtz D; Elmore L
Cancer Biol Ther; 2008 Jun; 7(6):864-72. PubMed ID: 18340112
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A.
Hou JG; Jeon BM; Yun YJ; Cui CH; Kim SC
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871042
[TBL] [Abstract][Full Text] [Related]
3. Premature senescence in human breast cancer and colon cancer cells by tamoxifen-mediated reactive oxygen species generation.
Lee YH; Kang BS; Bae YS
Life Sci; 2014 Mar; 97(2):116-22. PubMed ID: 24361399
[TBL] [Abstract][Full Text] [Related]
4. PTTG1 attenuates drug-induced cellular senescence.
Tong Y; Zhao W; Zhou C; Wawrowsky K; Melmed S
PLoS One; 2011; 6(8):e23754. PubMed ID: 21858218
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-Mediated miR-433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR-Independent Manner.
Vulpis E; Cuollo L; Borrelli C; Antonangeli F; Masuelli L; Cippitelli M; Fionda C; Caracciolo G; Petrucci MT; Santoni A; Zingoni A; Soriani A
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047835
[TBL] [Abstract][Full Text] [Related]
6. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
7. Senescent Colon and Breast Cancer Cells Induced by Doxorubicin Exhibit Enhanced Sensitivity to Curcumin, Caffeine, and Thymoquinone.
El-Far AH; Darwish NHE; Mousa SA
Integr Cancer Ther; 2020; 19():1534735419901160. PubMed ID: 32054357
[TBL] [Abstract][Full Text] [Related]
8. c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.
Udden SM; Morita-Fujimura Y; Satake M; Ikawa S
Cell Signal; 2014 Feb; 26(2):444-52. PubMed ID: 24177958
[TBL] [Abstract][Full Text] [Related]
9. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
[TBL] [Abstract][Full Text] [Related]
10. Diversity of the Senescence Phenotype of Cancer Cells Treated with Chemotherapeutic Agents.
Bojko A; Czarnecka-Herok J; Charzynska A; Dabrowski M; Sikora E
Cells; 2019 Nov; 8(12):. PubMed ID: 31771226
[TBL] [Abstract][Full Text] [Related]
11. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction.
Elmore LW; Rehder CW; Di X; McChesney PA; Jackson-Cook CK; Gewirtz DA; Holt SE
J Biol Chem; 2002 Sep; 277(38):35509-15. PubMed ID: 12101184
[TBL] [Abstract][Full Text] [Related]
12. Roles of estrogen receptor and p21(Waf1) in bortezomib-induced growth inhibition in human breast cancer cells.
Maynadier M; Shi J; Vaillant O; Gary-Bobo M; Basile I; Gleizes M; Cathiard AM; Wah JL; Sheikh MS; Garcia M
Mol Cancer Res; 2012 Nov; 10(11):1473-81. PubMed ID: 22964432
[TBL] [Abstract][Full Text] [Related]
13. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin.
Di X; Shiu RP; Newsham IF; Gewirtz DA
Biochem Pharmacol; 2009 Apr; 77(7):1139-50. PubMed ID: 19185564
[TBL] [Abstract][Full Text] [Related]
15. Depletion of securin induces senescence after irradiation and enhances radiosensitivity in human cancer cells regardless of functional p53 expression.
Chen WS; Yu YC; Lee YJ; Chen JH; Hsu HY; Chiu SJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):566-74. PubMed ID: 20457353
[TBL] [Abstract][Full Text] [Related]
16. Induction of p53-mediated senescence is essential for the eventual anticancer therapeutic effect of RH1.
Jung J; Song DY; Hwang JJ; Park HJ; Lee JS; Song SY; Jeong SY; Choi EK
Arch Pharm Res; 2019 Sep; 42(9):815-823. PubMed ID: 30879173
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
18. Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
Huang M; Whang P; Lewicki P; Mitchell BS
Mol Pharmacol; 2011 Jul; 80(1):40-8. PubMed ID: 21464199
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA.
Jaiswal AS; Multani AS; Pathak S; Narayan S
Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717
[TBL] [Abstract][Full Text] [Related]
20. The role of serotonin and p53 status in the radiation-induced bystander effect.
Kalanxhi E; Dahle J
Int J Radiat Biol; 2012 Oct; 88(10):773-6. PubMed ID: 22803606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
